Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
2011

Effects of COX-1 and COX-2 Inhibitors on Ovarian Cancer in Mice

Sample size: 24 publication 10 minutes Evidence: moderate

Author Information

Author(s): Li Wei, Wang Jie, Jiang Hong-Ru, Xu Xiao-Li, Zhang Jun, Mei-Lin Zhai, Ling-Yun

Primary Institution: Nanjing Medical University of Hangzhou Hospital

Hypothesis

A combination of COX-1 and COX-2 selective inhibitors should reduce the growth of tumors more effectively than either agent alone.

Conclusion

The combination of COX-1 and COX-2 selective inhibitors significantly suppressed tumor growth in ovarian cancer models.

Supporting Evidence

  • The combination of SC-560 and celecoxib showed a 35.54% reduction in tumor growth compared to the control group.
  • Cell proliferation was significantly lower in the combination group compared to the control group.
  • The apoptosis index was significantly higher in the combination group than in the control group.

Takeaway

Using two special medicines together can help stop cancer from growing better than using just one medicine.

Methodology

Mice with human ovarian cancer cells were treated with COX-1 and COX-2 inhibitors, and tumor growth was measured over three weeks.

Limitations

The study was conducted in a mouse model, which may not fully replicate human ovarian cancer.

Participant Demographics

Nude female mice, 7-8 weeks old.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/ijms12010668

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication